Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SRDX | Common Stock | Options Exercise | $88.1K | +4.37K | +18.05% | $20.18 | 28.6K | Nov 28, 2022 | Direct | |
transaction | SRDX | Common Stock | Sale | -$152K | -4.37K | -15.29% | $34.89 | 24.2K | Nov 28, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SRDX | Stock Option (right to buy) | Options Exercise | $0 | -4.37K | -100% | $0.00* | 0 | Nov 28, 2022 | Common Stock | 4.37K | $20.18 | Direct | F2 |
Id | Content |
---|---|
F1 | The amount beneficially owned includes 11,985 restricted stock units (RSUs) that vest on service-based vesting dates and 8,430 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends. |
F2 | Fully vested. |